Southpoint Capital Advisors LP
At a glance: Southpoint Capital Advisors LP is 10% Owner at Fennec Pharmaceuticals (FENC). Their latest SEC Form 4, filed Dec 29, 2025, reported a sale of $7.5M. On file: 0 purchase lines ($0) and 1 sale line ($7.5M).
Disclosed holdings: about $37.6M of FENC stock: 2,744,741 shares (including shares held indirectly, e.g. through a trust or fund) reported on its latest Form 4 (filed Dec 29, 2025), valued at the Nov 19, 2026 close of $13.69. This counts only FENC shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
10% Owner at Fennec Pharmaceuticals Inc. (FENC)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 29SEC | FENCFennec Pharmaceuticals Inc. | Sell | 1,000,0002,744,741 held (−27%) | $7.50 | $7.5M | +82.5% |
- Sell
10% Owner Southpoint Capital Advisors Lp sold $7.5M of FENC at $7.50 — cuts the stake by 27%.
Follow Southpoint Capital Advisors LP
Get one email when Southpoint Capital Advisors LP files a new purchase or sale. Free.
At most one email a day about Southpoint Capital Advisors LP, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.